2022•PrescriberOpen access

Erectile dysfunction therapy after prostate cancer treatment

Victoria Stainer, Rachel Skews, Jonathan J. Aning

Abstract

Erectile dysfunction (ED) is a common complication of prostate cancer treatment. In the second of this two‐part series on the management of erectile dysfunction following treatment for localised prostate cancer, the authors discuss the therapeutic options available for ED after prostate cancer treatment and their advantages and disadvantages.

Open-access reader

About this research paper

What this paper is about

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Erectile dysfunction, Prostate cancer, Prostate, Management of prostate cancer, Cancer, Urology, Oncology